Dr. Schiff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Fl 3
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-982-4467
Education & Training
- Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
- Harvard Medical SchoolClass of 1988
Certifications & Licensure
- AZ State Medical License 1996 - Present
- VA State Medical License 2001 - 2026
- PA State Medical License 1996 - 2002
- MN State Medical License 1993 - 1997
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.Anthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, Michael C Dewan, Benita Tamrazi
Neuro-Oncology. 2024-12-05 - Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth.Collin J Dube, Ying Zhang, Shekhar Saha, Michelle Lai, Myron K Gibert
Biorxiv. 2024-08-23 - An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mapping.Rugved Chavan, Gabriel Hyman, Zoraiz Qureshi, Nivetha Jayakumar, William Terrell
Biomedical Physics & Engineering Express. 2024-08-19
Journal Articles
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
Other
- Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-10-03 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-04-09 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-08-28 - Join now to see all
Press Mentions
- Trial Identifies Better Treatment for Grade 2 GliomasDecember 3rd, 2024
- Adding Temozolomide to Radiation Therapy May Improve Survival in Adults with Low-Grade GliomasNovember 26th, 2024
- New Brain Cancer Guidelines to Improve Care, Patient SurvivalJanuary 26th, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: